Accessibility Menu
Raffles Medical Group logo

Raffles Medical Group(SGX) BSL

Market CapSGD 1.59BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1997)+1,238%
5 Year-39%
1 Year-15%
1 Month-2%
SGD 0.86
-0.58%
-0.00Today
Raffles Medical Group last closing stock price
MetricPriceDate
Last closeSGD 0.862026-09-01
Raffles Medical Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.58%SGD 0.872026-08-25
1 month-2.27%SGD 0.882026-07-31
3 month-8.99%SGD 0.952026-06-03
Year to date-15.69%SGD 1.022025-12-31
1 year-14.85%SGD 1.012025-09-01
3 year-31.75%SGD 1.262023-08-31
5 year-39.44%SGD 1.422021-09-02
Since inception+1,237.54%SGD 0.061997-04-14

Raffles Medical Group Financials at a Glance

Market Cap

SGD 1.59BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SGD 740.31M

Net Income (TTM)

SGD 67.48M

EPS (TTM)

SGD 0.04

P/E Ratio

23.63

Dividend

SGD 0.03

Beta (Volatility)

-0.08 (Low)

Price

SGD 0.86

Volume

779,700

Open

SGD 0.87

Previous Close

SGD 0.87

Daily Range

SGD 0.86 - SGD 0.87

52-Week Range

SGD 0.85 - SGD 1.08

Estimated Earnings Date

Feb 22, 2027

BSL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Raffles Medical Group

Raffles Medical Group Ltd is a leading healthcare provider based in Singapore, offering integrated private healthcare services across multiple regions, including Greater China, Vietnam, Cambodia, and Japan. The company operates through various segments, including Healthcare Services, Hospital Services, and Investment Holdings, with Raffles Hospital as its flagship facility.

Products and Services
  • Comprehensive medical services including oncology, pediatrics, and women's health
  • Emergency services, family medicine, and health screening
  • Pharmaceutical trade and IT solutions in healthcare
Growth Outlook
  • Expansion into Greater China and Southeast Asia enhances market reach
  • Increasing demand for private healthcare services supports revenue growth
  • Investment in technology and research drives innovation in healthcare delivery
Financial Highlights
  • Recent quarterly revenue of SGD 176.6 million, consistent with previous quarters
  • Net income of SGD 14.5 million, reflecting stable profitability
  • TTM dividend yield of 3.41%, indicating attractive returns for investors
Raffles Medical Group Ltd has established itself as a prominent player in the healthcare sector, with a diverse range of services that cater to various medical needs. The company's strategic expansion into new markets and its commitment to innovation position it well for future growth. Recent financial performance demonstrates stability, with consistent revenue and net income figures, making it an appealing option for potential investors interested in the healthcare industry. The attractive dividend yield further enhances its investment appeal, reflecting the company's commitment to returning value to shareholders.
AI Generated • Aug 12, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

2,965

Website

www.rafflesmedicalgroup.com

Headquarters

Singapore, SE 188770, SG

BSL Financials

Key Financial Metrics (TTM)

Gross Margin

44.35%

Operating Margin

11.73%

Net Income Margin

9.12%

Return on Equity

6.42%

Return on Capital

7.62%

Return on Assets

4.88%

Earnings Yield

4.23%

Dividend Yield

3.47%

Payout Ratio

81.81%

Stock Overview

Market Cap

SGD 1.59BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.84B

Volume

779.70K

Avg. Volume

2.69M

Financials (TTM)

Gross Profit

SGD 328.32M

Operating Income

SGD 86.87M

EBITDA

SGD 113.62M

Operating Cash Flow

SGD 109.28M

Capital Expenditure

-SGD 8.06M

Free Cash Flow

SGD 101.22M

Cash & ST Invst.

SGD 262.30M

Total Debt

SGD 34.18M

Raffles Medical Group Performance Analysis

Raffles Medical Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31SGD 822,916,00013.7%
20232023-12-31SGD 706,920,000-14.1%
20242024-12-31SGD 751,564,0006.3%
20252025-12-31SGD 765,299,0001.8%
Raffles Medical Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-302.3%
Q42025-12-31N/A
Q12026-03-31-8.8%
Q22026-06-30N/A
Raffles Medical Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31SGD 0.0870.8%
20232023-12-31SGD 0.05-37.2%
20242024-12-31SGD 0.03-30.7%
20252025-12-31SGD 0.0414.1%
Raffles Medical Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3020.9%
Q42025-12-31N/A
Q12026-03-31-24.0%
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

SGD 176.60M

-6.7%

Gross Profit

SGD 77.45M

-10.9%

Gross Margin

43.86%

N/A

Market Cap

SGD 1.59BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

SGD 548.88K

N/A

Employees

2,900

N/A

Net Income

SGD 14.51M

-9.6%

EBITDA

SGD 29.62M

-5.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

SGD 262.30M

-21.5%

Total Debt

SGD 34.18M

-59.2%

Accounts Receivable

SGD 122.46M

-20.9%

Inventory

SGD 10.68M

-5.3%

Long Term Debt

SGD 22.36M

-20.6%

Short Term Debt

SGD 11.82M

-80.4%

Return on Assets

4.88%

N/A

Return on Invested Capital

8.06%

N/A

Free Cash Flow

SGD 30.76M

+14.4%

Operating Cash Flow

SGD 32.28M

+14.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About BSL

What is the current price of Raffles Medical Group?

Raffles Medical Group is trading at SGD 0.86 per share.

What is the 52-week range for Raffles Medical Group?

Over the past 52 weeks, Raffles Medical Group has traded between SGD 0.85 and SGD 1.08.

How much debt does Raffles Medical Group have?

As of the most recent reporting period, Raffles Medical Group reported total debt of SGD 87.42M.

How much cash does Raffles Medical Group have on hand?

Raffles Medical Group reported SGD 310.79M in cash and cash equivalents in its most recent financial results.

What is Raffles Medical Group’s dividend yield?

Raffles Medical Group currently has a dividend yield of 3.47%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services